Epstein-Barr Virus Involvement in T-Cell Malignancy: Significance in Adult T-Cell Leukemia

References

• Epstein M. A., Achong B. G., Barr Y. M. Virus particles in cultured lyhmphohlasts from Burkitt's lym‐phoma. Lancet 1964; I: 702–703
   Web of Science ®Google Scholar
• Klein E., Ernherg I., Masucci M. G., et al. T cell response to B cells and Epstein‐Ban virus antigens infectious mononucleosis. Cancer Res. 1981; 41: 4210–4215
   PubMed Web of Science ®Google Scholar
• Sumaya C. V., Ench Y. Epstein‐Ban virus infections in family: the role of children with infectious mononucleosis. J. Infect. Dis. 1986; 154: 842–850
   PubMed Web of Science ®Google Scholar
• Ho M., Miller G., Atchinson R. W., et al. Epstein‐Ban virus infection and DNA hybridization studies in post‐transplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J. Infect Dis. 1985; 152: 876–886
   PubMed Web of Science ®Google Scholar
• Shapiro R. S., McClain K., Frizzera G., et al. Epstein‐Barr virus‐associated B cell lymphoproliferative disorders following hone marrow transplantation. Blood 1988; 71: 1234–1243
   PubMed Web of Science ®Google Scholar
• Hanto D. W., Frizzera G., Gajl‐eczalska K. J., et al. Epstein‐Ban virus induced B‐cell lymphoma after renal transplantation: acyclovir therapy and transition from poly‐clonal to monoclonal B cell proliferation. N Engl J Med 1982; 306: 913–918
   PubMed Web of Science ®Google Scholar
• Borisch Chappuis B., Muller H., Stutte J., et al. Identification of EBV DNA in lymph nodes and lymphomas in AIDS. Virch. Arch. B. 1990; 58: 199–205
   Google Scholar
• Jones J. E., Shurin S., Ahramowsky C., Tubhs R. R., et al. T cell lymphomas contaiing Epstein‐Ban viral DNA in patients with chronic Epstein‐Ban virus infection. N Engl. J Med 1988; 318: 733–741
   PubMed Web of Science ®Google Scholar
• Fingeroth J. D., Benedict M. A., Levy D. N., Strominger J. L. Identificatin of murine complement receptor type 2. Proc Natl Acad Sci USA 1989; 86: 242–46
   PubMed Web of Science ®Google Scholar
• Mittler R. S., Talk M. A., Carpenter K., Rao P. E., Goldstein G. Generation and Characterization of monoclonal antibodies reactive with human B lymphocytes. J. Immunol 1983; 131: 1754–61
   PubMed Web of Science ®Google Scholar
• Moore M. D., Cooper N. R., Tack B. F., Nemerow G. R. Molecular cloning of the cDNA encoding the Epstein‐Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Nal Acad Sci. USA 1987; 84: 9194–98
   PubMed Web of Science ®Google Scholar
• Kai C., Okada N., Okada H. Expression of CR2 (CD3d receptor) on the cell membranes of adult T cell lenkemia. Jpn J Cancer Res 1988; 79: 805–8
   PubMedGoogle Scholar
• Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus (ATLV) from cell lines of adult T cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031–35
   PubMed Web of Science ®Google Scholar
• Okamoto T., Ohno Y., Tsugane S., Watanahe S., Shi‐moyama M., Tajima K., Miwa M., Shimotohno K. Multi‐step carcinogenesis model for adult T‐cell leukemia. Jpn J Cancer Res 1989; 80: 191–95
   PubMedGoogle Scholar
• Nonoyama M., Huang C. H., Pagano J. S., Klein G., Singh S. DNA of Epstein‐Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci USA 1973; 70: 3265–68
   PubMed Web of Science ®Google Scholar
• Klein G., Giovanella B. C., Lindahl T., Fialkow P. J., Singh S., Stehlin J. S. Direct evidence for the presence of Epstein‐Ban virus DNA and nuclear antigen in malignant epithelial cells from patients with anaplastic carcinoma of the nasopharynx. Proc Natl Acad Sci USA 1974; 71: 4737–41
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Strickler J. G., Wamke R. A., et al. Epstein‐Barr virus DNA in tissues of Hodgkin's disease. Am J Pathol 1987; 129: 86–89
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Movahed L. A., Warnke R. A., et al. Detection of Epstein‐Barr virus genomes in Reed‐Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Kawa‐Ha K., Ishihara S., Ninomiya T., Yumura‐Yagi K., Hara J., Murayama F., Tawa A., Hirai K. CD3‐negative lymphoproliferative disease of granular lymphocytes containing Epstein‐Barr viral DNA. J Clin Invest 1989; 84: 51–55
   PubMed Web of Science ®Google Scholar
• Sample J. T. Epstein‐Barr virus ‐ Molecular biology. Encyclopedia of Virology, R. G. Webster, A. Gra‐noff. Academic Press, New York 1994; 410–416
   Google Scholar
• Rawlins D. R., Milman G., Hayward S. D., Hayward G. S. Sequence‐specific DNA binding of the Epstein‐Barr virus nuclear antigen (EBNA‐1) to clustered sites in the plasmid maintenance region. Cell 1985; 42: 859–68
   PubMed Web of Science ®Google Scholar
• Sixbewy J. W., Shirley P., Sloas M., Raab‐Traub N., Israele V. A transformation‐incompetent, nuclear antigen 2‐depleted Epstein‐Barr virus associated with repli‐cative infection. J Infect Dis 1991; 163: 1008–15
   PubMed Web of Science ®Google Scholar
• Kaye K. M., Izumi K., Kieff E. Epstein‐Barr virus latent membrane protein 1 is essential for B‐lympho‐cyte growth transformation. Proc Natl Acad Sci USA 1993; 90: 9150–54
   PubMed Web of Science ®Google Scholar
• Tomkinson B., Robertson E., Kieff E. Epstein‐Barr virus nuclear proteins EBNA‐3A and EBNA‐3C are essential for B‐lymphocyte growth transformation. J Virol 1993; 67: 2014–25
   PubMed Web of Science ®Google Scholar
• Swaminathan S., Tomkinson B., Kieff E. Recombiant Epstein‐Ban virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci USA 1991; 88: 1546–50
   PubMed Web of Science ®Google Scholar
• Cordier M., Calender A., Billaud M., Zimber U., Rousselet G., Pavlisyh O., Banchereau J., Tursz T., Bomkamm G., Lenoir G. M. Stable transfection of Epstein‐Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3H1 genome. J Virol 1990; 64: 1002–13
   PubMed Web of Science ®Google Scholar
• Kanno H., Yasunaga Y., Ohsawa M., Taniwaki M., Iuchi K., Naka N., Toriaki K., Shimoyama M., Aozasa K. Exression of Epstein‐Barr virus latent infection gene and oncogenes in lymphoma cell lines derived from pyotho‐rax‐associated lymphoma. Int J Cancer 1996; 67: 86–94
   PubMed Web of Science ®Google Scholar
• Szekeryi L., Selivanova G., Magnusson K. P., et al. EBNA‐5, an Epstein‐Barr virus‐encoded antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 1993; 90: 5455–59
   PubMed Web of Science ®Google Scholar
• Peng M., Lundgren E. Transient expression of the Epstein‐Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene 1992; 7: 1775–82
   PubMed Web of Science ®Google Scholar
• Roberts M. L., Cooper N. R. Activatin of a ras‐MAPK‐dependent pathway by Epstein‐Bm virus latent membrane protein 1 is essential for cellular transformation. Virology 1998; 240: 93–99
   PubMed Web of Science ®Google Scholar
• Laherty C. D., Hu H. M., Opipari A. W., Wang F., Dixit V. M. The Epstein‐Barr virus LMPI gene product induces A20 zinc finger protein expressin by activating nuclear factor kappa. B. J Biol Chem. 1992; 267: 24157–60
   PubMed Web of Science ®Google Scholar
• Henderson S., Rowe M., Gregory C., Croom‐Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Inductin of bcl‐2 expression by Epstein‐Ban virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–15
   PubMed Web of Science ®Google Scholar
• Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinosh‐ita T., Mizuno F., Osato T. Epstein‐Barr virus in nasal T‐cell lymphomas in patients with lethal midline granu‐loma. Lancet 1990; 335: 128–130
   PubMed Web of Science ®Google Scholar
• Pan L., Diss T. C., Peng H., Lu Q., Wotherspoon A. C., Thomas J. A., Isaacson P. G. Epstein‐Barr virus (EBV) in enteropathy‐associated T‐cell lymphoma (EATL). J Pathol 1993; 170: 137–43
   PubMed Web of Science ®Google Scholar
• Tsai T. F., Su I. J., Lu Y. C., Cheng A. L., Yeh H. P., Hsieh H. C., Tien H. E., Chen J. S., Uen W. C. Cutaneous angiocentric T‐cell lymphoma associated with Epstein‐Barr virus. J Am Acad Dermatol 1992; 26: 31–38
   PubMed Web of Science ®Google Scholar
• Su I. J., Hsieh H. C. Clinicopathological spectrum of Epstein‐Barr virus‐associated T cell malignancies. Leukemia and Lymphoma 1992; 7: 47–53
   PubMed Web of Science ®Google Scholar
• Su I. J., Hsieh H. C., Lin K. H., Uen W. C., Kao C. L., Chen C. J., Cheng A. L., Kadin M. E., Chen J. Y. Aggressive peripheral T‐cell lymphomas containing Epstein‐Barr virus DNA: a clinicopathologic and molecular analysis. Blood 1991; 77: 799–808
   PubMed Web of Science ®Google Scholar
• Cheng A. L., Su I. J., Chen Y. C., Wen W. C., Wang C. H. Characteristic clinicopathologic features of Epstein‐Ban virus‐associated peripheral T‐cell lymphoma. Cancer 1993; 72: 909–1016
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Hummel M., Kaudewitz P., Korbjuhn P., Leoncini L., Stein M. Low incidence of Epstein‐Barr virus presence in primary cutaneous T‐cell lym‐phoproliferations. Br‐ J Dermatol 1996; 134: 276–81
   PubMed Web of Science ®Google Scholar
• Allday M. J., Crawford D. H., Griffin B. E. Epstein‐Barr virus latent gene expressin during the initiation of B cell immortalization. J Gen Virol 1989; 70: 1755–64
   PubMed Web of Science ®Google Scholar
• Niedobitek G., Agathanggelou A., Rowe M., Jones E. L., Jones D. B., Turyagnuma P., Oryema J., Wright D. H., Young L. S. Heterogeneous expression of Epstein‐Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 1995; 86: 659–65
   PubMed Web of Science ®Google Scholar
• Young L. S., Dawson C. W., Clark D., Rupani H., Busson P., Tursz T., Johnson A., Rickinson A. B. Epstein‐Bm virus gene expression in uasopharyngeal carci‐noma. J Gen Virol 1988; 69: 1051–65
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton‐Dutoit S. J., Rowe M., Lisse I., Ralfkiaer E., Sandvej K., Young L. S. Expression of Epstein‐Barr virus replicative proteins in AIDS‐related non‐Hodgkin's lymphoma cells. J Pathol 1991; 165: 289–99
   PubMed Web of Science ®Google Scholar
• Chen C. L., Sadler R. H., Walling D. M., Su I. J., Hsieh H. C., RaabTraub N. Epstein‐Ban virus (EBV) gene expression in EBV‐positive peripheral T‐cell lymphomas. J Virol 1993; 67: 6303–08
   PubMed Web of Science ®Google Scholar
• Woisetschlaeger M., Strominger J. L., Speck S. H. Mutually exclusive use of viral promoters in Epstein‐Barr virus latently infected lymphocytes. Proc Natl Acad Sci USA 1989; 86: 6498–502
   PubMed Web of Science ®Google Scholar
• Brooks L., Yao Q. Y., Rickinson A. B., Young L. S. Epstein‐Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcript. J Virol 1992; 66: 2689–97
   PubMed Web of Science ®Google Scholar
• Koizumi S., Zhang X. K., Imai S., Sigiura M., Usui N., Osato T. Infection of the HTLV‐I‐harbouring T‐lym‐phoblastoid line MT‐2 by Epstein‐Barr virus. virology 1992; 188: 859–63
   PubMed Web of Science ®Google Scholar
• Tsoukas C. D., Lambris J. D. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 1988; 18: 1299–302
   PubMed Web of Science ®Google Scholar
• Fischer E., Delibrias C., Kazatchkine M. D. Expression of CR2 (the C3dR/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 1991; 146: 865–69
   PubMed Web of Science ®Google Scholar
• Ohtsubo H., Arima N., Matsushita K., Hidaka S., Fuji‐wara H., Arimura K., Kukita T., Fukumori J., Matsumoto T., Eizuru Y., Tanaka H. Human T lymphotropic virius‐type I Tax induction of CD21/Epstein‐Barr virus receptor expression on T cells and its significance in leuke‐mogenesis of adult T cell leukema. Exp Hematol 1997; 25: 1246–52
   PubMed Web of Science ®Google Scholar
• Rayhel E. J., Dehoff M. H., Holers V. M. Characterization of the human complement receptor 1 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. J Immunol 1991; 146: 2021–26
   PubMed Web of Science ®Google Scholar
• Imai S. Virological and immunological studies on inapparent Epstein‐Barr virus infection in healthy individuals: In comparison to immunosuppressed patients and patients with infectious mononucleosis. Hokkaido Igaku Zasshi 1990; 65: 481–92
   PubMedGoogle Scholar
• Seiki M., Hattori S., Yoshida M. Human adult T‐cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci USA 1982; 79: 6899–902
   PubMed Web of Science ®Google Scholar
• Chen I. S. Y., Slamon D. J., Rosenblatt J. D., Shah N. P., Quan S. G., Wachsman W. The X gene is essential for HTLV replication. Science 1985; 299: 54–58
   Web of Science ®Google Scholar
• Seiki M., Hikikoshi A., Taniguchi T., Yoshida M. Expression of the pX gene of HTLV‐I: general splicing mechanims in the HTLV family. Science 1985; 228: 1532–34
   PubMed Web of Science ®Google Scholar
• Inoue J. ‐K., Yoshida M., Seiki M. Transcrip‐tional (p40x) and post‐transcriptional (p27x‐III) regulators are required for expression of the HTLV‐I genes. Proc Natl Acad Sci USA 1987; 84: 3653–57
   PubMed Web of Science ®Google Scholar
• Inoue J., Seiki M., Taniguchi T., Tsuru S., Yoshida M. Induction of interleukin‐2 receptor gene expression by p40X encoded by human T‐cell leukemia virus type I. EMBO J 1986; 5: 2883–88
   PubMed Web of Science ®Google Scholar
• Cross S. L., Feinberg M. B., Wolf J. B., Holbrook N. J., Wong‐Staal F., Leonard W. J. Regulation of the human interleukin‐2 receptor a chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV‐I. Cell 1987; 49: 47–56
   PubMed Web of Science ®Google Scholar
• Fujii M., Sassone‐Corsi P., Verma I. M. c‐fos promoter transactivation by the tax protein of human T‐cell leukemia virus type I. Proc Natl Acad Sci USA 1988; 85: 8526–30
   PubMed Web of Science ®Google Scholar
• Baliard D. W., Bohnlein E., Lowenthal J. W., Wano Y., Franza B. R., Greene W. C. HTLV‐I tax induces cellular proteins that activate the kappa B element in the IL‐2 receptor alpha gene. Science 1988; 241: 1652–55
   PubMed Web of Science ®Google Scholar
• Leung K., Nabel G. J. HTLV‐I transactivator induced interleukin‐2 receptor expression through and NF‐kappa B‐like factor. Nature 1988; 333: 776–78
   PubMed Web of Science ®Google Scholar
• Ruben S., Poteat H., Tan T. H., Kawakami K., Roeder R., Haseltine W., Rosen C. A. Cellular transcription factors and regulation of IL‐2 receptor gene expression by HTLV‐I tax gene product. Science 1988; 241: 89–92
   PubMed Web of Science ®Google Scholar
• Jeang K. T., Boros I., Brady J., Radonovich M., Khoury G. Characterization of cellular factors that interact with the human T‐cell leukemia virus type I p40X ‐responsive 21 base‐pair sequence. J Virol 1988; 62: 4499–509
   PubMed Web of Science ®Google Scholar
• Maruyama M., Shibuya H., Harada H., Hatakeyama M., Seiki M., Fujita T., Inoue J., Yoshida M., Taniguchi T. Evidence for aberrant activation of the interleukin‐2 autocrine loop by HTLV‐I encoded p40X and T3/Ti complex triggering. Cell 1987; 48: 343–50
   PubMed Web of Science ®Google Scholar
• Yokota J., Sugimura T. Multile steps in carcino‐genesis involving alterations of multiple tumor suppressor genes. FASEB J 1993; 7: 920–25
   PubMed Web of Science ®Google Scholar
• Sakashita A., Hattori T., Miller C. W., Suzushima H., Asou N., Takatsuki K., Koeffler H. P. Mutations of the p53 gene in adult T‐cell leukemia. Blood 1992; 79: 477–80
   PubMed Web of Science ®Google Scholar
• Hatta Y., Hirama T., Miller C. W., Yamada Y., Tomonaga M., Koeffler H. P. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T‐cellleukemia. Blood 1995; 85: 2699–704
   PubMed Web of Science ®Google Scholar
• Maeda M., Shimiziui A., Ikuta K., Okamoto H., Kashi‐hara M., Uchiyama T., Honjo T., Yodoi J. Origin of human T‐lymphotrophic virus I positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med 1985; 162: 2169–74
   PubMed Web of Science ®Google Scholar
• Kawano F., Yamaguchi K., Nishimura H., Tsuda H., Takatsuki K. Variation in the clincial courses of adult T‐cell leukemia. Cancer 1985; 55: 851–56
   PubMed Web of Science ®Google Scholar
• Tokunaga M., Imai S., Uemura Y., Tokudome T., Osato T., Sato E. Epstein‐Ban virus in adult T‐cell leuke‐mia/lymphoma. Am J Pathol 1993; 143: 1263–68
   PubMed Web of Science ®Google Scholar
• Arima N. Autonomous and interleukin‐2‐responsive growth of leukemic cells in adult T‐cell leukemia (ATL): a review of the clinical significance and molecular basis of ATL cell growth. Leukemia and Lymphoma 1997; 26: 479–87
   PubMed Web of Science ®Google Scholar